tiprankstipranks
Altimmune Inc (GB:0A4C)
LSE:0A4C

Altimmune (0A4C) Financial Statements

0 Followers

Altimmune Financial Overview

Altimmune's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Altimmune is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.35. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 5.00K$ 37.00K$ 362.00K$ 6.00K$ 21.00K
Gross Profit$ 5.00K$ 37.00K$ 362.00K$ 6.00K$ 21.00K
EBIT$ -24.39M$ -31.64M$ -20.64M$ -16.06M$ -20.07M
EBITDA$ -24.29M$ -29.75M$ -20.64M$ -16.06M$ -20.07M
Net Income Common Stockholders$ -24.39M$ -31.64M$ -20.67M$ -16.06M$ -20.07M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 182.02M$ 197.81M$ 140.78M$ 160.00M$ 165.76M
Total Assets$ 188.36M$ 210.64M$ 166.57M$ 183.32M$ 187.08M
Total Debt$ 0.00$ 0.00$ 4.30M$ 4.17M$ 4.40M
Net Debt$ -182.02M$ -197.81M$ -136.47M$ -155.83M$ -161.36M
Total Liabilities$ 11.33M$ 16.54M$ 16.18M$ 15.60M$ 19.35M
Stockholders Equity$ 172.94M$ 194.10M$ 150.40M$ 167.71M$ 167.73M
Cash Flow-
Free Cash Flow$ -16.36M$ -16.53M$ -20.49M$ -19.38M$ -19.46M
Operating Cash Flow$ -16.36M$ -16.53M$ -20.49M$ -19.38M$ -19.41M
Investing Cash Flow$ -39.52M$ -7.96M$ 4.40M$ 3.99M$ 13.30M
Financing Cash Flow$ -261.00K$ 72.75M$ 588.00K$ 13.06M$ -302.00K
Currency in USD

Altimmune Earnings and Revenue History

Altimmune Debt to Assets

Altimmune Cash Flow

Altimmune Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis